COVID-19
Top Fauci Aide Allegedly Learned To Make ‘Smoking Gun’ Emails ‘Disappear,’ Testimony Reveals

From the Daily Caller News Foundation
By JASON COHEN
“Dr. David Morens, a senior advisor to Fauci for decades, wrote in an email to Dr. Daszak, ‘I learned from our FOIA lady here how to make emails disappear after I am FOIA’d, but before the search starts. So I think we are all safe.
National Institutes of Health (NIH) Principal Deputy Director Lawrence Tabak testified on Thursday that a former aide to Dr. Anthony Fauci allegedly violated the agency’s public records policy by disposing of certain emails.
Fauci’s senior advisor at the NIH Dr. David Morens allegedly intentionally obstructed the House Select Subcommittee on the Coronavirus Pandemic’s investigations into the origins of COVID-19 to protect his boss. Tabak told Republican House Oversight Chair James Comer in response to his questioning during a hearing that Morens allegedly violated NIH policy by getting rid of emails following public records requests.
WATCH:
“Dr. David Morens, a senior advisor to Fauci for decades, wrote in an email to Dr. Daszak, ‘I learned from our FOIA lady here how to make emails disappear after I am FOIA’d, but before the search starts. So I think we are all safe. Plus I deleted most of those earlier emails after sending them to Gmail.’ Is that consistent with NIH document retention policies?” Comer asked, to which Tabak answered that it’s not.
EcoHealth Alliance President Peter Daszak allegedly misled the federal government to receive grants that funded virus research at the Wuhan Institute of Virology, where some suspect the COVID-19 pandemic originated.
“Does the NIH FOIA office teach employees how to avoid transparency?” Comer followed up.
“I certainly hope not,” Tabak said.
Daszak appeared for a transcribed interview in November 2023, where he called Morens a “mentor.”
“He also later wrote Dr. Daszak, ‘We are all smart enough to know to never have smoking guns and if we did, we wouldn’t put them in emails. And if we found them, ‘we would delete them,” Comer said, again asking if this is consistent with agency policy and Tabak again saying it’s not.
“Finally, emails show that Dr. Morens would share internal questions about upcoming FOIA releases with Dr. Daszak. He would then help Dr. Daszak craft responses to documents being released in these FOIAs. Are those actions consistent with NIH policies?” Comer asked.
Tabak expressed uncertainty about whether these actions took place, but said they would not be consistent with agency policy.
Morens in 2021 sent an email to Daszak, explaining that he tries “to always communicate on gmail because [his] NIH email is FOIA’d constantly,” The Intercept reported.
U.S. Right to Know is one organization that submitted public records requests to the NIH for emails Morens sent regarding content related to the origins of the COVID-19 pandemic. It is currently engaged in litigation with the agency for its lack of compliance with a January 2022 request.
The Department of Health and Human Services (HHS) on Wednesday informed EcoHealth Alliance that the federal government would be suspending current grants to the nonprofit and it is striving to block it from getting more grants. HHS cites a series of mistakes EcoHealth Alliance made, including issues with the organization’s monitoring of work at the Wuhan Institute of Virology.
COVID-19
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

From LifeSiteNews
The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.
In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).
Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.
Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.
Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).
COVID-19
Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
-
International22 hours ago
Pentagon Salivates Over ‘Expensive’ Weapons While China Races Into Future With Iron Grip Over Cheap Drone Tech
-
Crime2 days ago
Canada Blocked DEA Request to Investigate Massive Toronto Carfentanil Seizure for Terror Links
-
Business1 day ago
Top Canadian bank ditches UN-backed ‘net zero’ climate goals it helped create
-
Alberta23 hours ago
Pierre Poilievre will run to represent Camrose, Stettler, Hanna, and Drumheller in Central Alberta by-election
-
COVID-191 day ago
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’
-
Business2 days ago
Overregulation is choking Canadian businesses, says the MEI
-
Health23 hours ago
RFK Jr. orders placebo safety trials for all new vaccines in major policy decision
-
Business22 hours ago
Federal government’s accounting change reduces transparency and accountability